Literature DB >> 6145359

Case report of neuroleptic malignant syndrome associated with withdrawal from amantadine.

D M Simpson, G C Davis.   

Abstract

Withdrawal of dopamine agonists may precipitate or exacerbate neuroleptic malignant syndrome. This case report of neuroleptic malignant syndrome following withdrawal of neuroleptics and amantadine suggests that dopamine agonists should not be discontinued in hyperpyrexic patients at risk for this syndrome.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6145359     DOI： 10.1176/ajp.141.6.796

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


  11 in total

1.  Case files of the program in medical toxicology at brown university: amantadine withdrawal and the neuroleptic malignant syndrome.

Authors:  Eric Brantley; Jamieson Cohn; Kavita Babu
Journal:  J Med Toxicol       Date:  2009-06

2.  A Complex Presentation of Pediatric Neuroleptic Malignant Syndrome Related to Polypharmacy in a 12-Year-Old Male.

Authors:  Nathaniel Sharon; Chandra Cullen; Kara Martinez
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-07-01       Impact factor: 2.576

Review 3.  Clinical management of neuroleptic malignant syndrome.

Authors:  V L Susman
Journal:  Psychiatr Q       Date:  2001

Review 4.  Movement disorder emergencies.

Authors:  Steven J Frucht
Journal:  Curr Neurol Neurosci Rep       Date:  2005-07       Impact factor: 5.081

5.  Amantadine and the glutamate hypothesis of schizophrenia. Experiences in the treatment of neuroleptic malignant syndrome.

Authors:  J Kornhuber; M Weller
Journal:  J Neural Transm Gen Sect       Date:  1993

Review 6.  Movement disorder emergencies.

Authors:  Kathleen L Poston; Steven J Frucht
Journal:  J Neurol       Date:  2008-08       Impact factor: 4.849

7.  Hyperthermic syndromes and impairment of the dopaminergic system: a clinical study.

Authors:  L Figà-Talamanca; C Gualandi
Journal:  Ital J Neurol Sci       Date:  1989-02

8.  MRI white matter hyperintensity in neuroleptic malignant syndrome (NMS)--a clue to pathogenesis?

Authors:  T Becker; J Kornhuber; E Hofmann; M Weller; C Rupprecht; H Beckmann
Journal:  J Neural Transm Gen Sect       Date:  1992

Review 9.  Aetiology and treatment of neuroleptic malignant syndrome.

Authors:  C Harpe; A Stoudemire
Journal:  Med Toxicol       Date:  1987 May-Jun

10.  Neuroleptic malignant syndrome.

Authors:  A V Srinivasan; M Murugappan; S G Krishnamurthy; Z A Sayeed
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-06       Impact factor: 10.154
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.